MDXG Q4 2020 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$69M-10.3% YoY

Gross Profit

$58M84.2% margin

Operating Income

-$16M-23.5% margin

Net Income

-$17M-24.2% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+6.6%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$202M

Total Liabilities

$111M

Stockholders' Equity

$91M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$76M	-10.3%
Gross Profit	$58M	$64M	-9.4%
Operating Income	-$16M	-$5M	-230.3%
Net Income	-$17M	-$7M	-121.8%